Literature DB >> 29072032

Training-induced annual changes in red blood cell profile in highly-trained endurance and speed-power athletes.

Monika Ciekot-Sołtysiak1, Krzysztof Kusy2, Tomasz Podgórski3, Jacek Zieliński2.   

Abstract

BACKGROUND: An extensive body of literature exists on the effects of training on hematological parameters, but the previous studies have not reported how hematological parameters respond to changes in training loads within consecutive phases of the training cycle in highly-trained athletes in extremely different sport disciplines. The aim of this study was to identify changes in red blood cell (RBC) profile in response to training loads in consecutive phases of the annual training cycle in highly-trained sprinters (8 men, aged 24±3 years) and triathletes (6 men, aged 24±4 years) who competed at the national and international level.
METHODS: Maximal oxygen uptake (VO2max), RBC, hemoglobin (Hb), hematocrit (Ht), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and RBC distribution width (RDW) were determined in four characteristic training phases (transition, general subphase of the preparation phase, specific subphase of the preparation phase and competition phase).
RESULTS: Our main findings are that: 1) Hb, MCH and MCHC in triathletes and MCV in both triathletes and sprinters changed significantly over the annual training cycle; 2) triathletes had significantly higher values than sprinters only in case of MCH and MCHC after the transition and general preparation phases but not after the competition phase when MCH and MCHC were higher in sprinters; and 3) in triathletes, Hb, MCH and MCHC substantially decreased after the competition phase, which was not observed in sprinters. The athletes maintained normal ranges of all hematological parameters in four characteristic training phases.
CONCLUSIONS: Although highly-trained sprinters and triathletes do not significantly differ in their levels of most hematological parameters, these groups are characterized by different patterns of changes during the annual training cycle. Our results suggest that when interpreting the values of hematological parameters in speed-power and endurance athletes, a specific phase of the annual training cycle should be taken into account.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29072032     DOI: 10.23736/S0022-4707.17.07819-7

Source DB:  PubMed          Journal:  J Sports Med Phys Fitness        ISSN: 0022-4707            Impact factor:   1.637


  5 in total

1.  The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β1 and non-selective β1 + β2 adrenergic receptor blockade.

Authors:  Rod J Azadan; Nadia H Agha; Hawley E Kunz; Forrest L Baker; Preteesh L Mylabathula; Tracy A Ledoux; Daniel P O'Connor; Charles R Pedlar; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

Review 2.  Metabolic interaction between purine nucleotide cycle and oxypurine cycle during skeletal muscle contraction of different intensities: a biochemical reappraisal.

Authors:  Piero L Ipata; Rossana Pesi
Journal:  Metabolomics       Date:  2018-02-27       Impact factor: 4.290

3.  Life-long sports engagement enhances adult erythrocyte adenylate energetics.

Authors:  Barbara Pospieszna; Krzysztof Kusy; Ewa Maria Slominska; Jacek Zieliński
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

4.  The Effect of Training on Erythrocyte Energy Status and Plasma Purine Metabolites in Athletes.

Authors:  Barbara Pospieszna; Krzysztof Kusy; Ewa Maria Słomińska; Wioleta Dudzinska; Monika Ciekot-Sołtysiak; Jacek Zieliński
Journal:  Metabolites       Date:  2019-12-19

5.  Alterations in Exercise-Induced Plasma Adenosine Triphosphate Concentration in Highly Trained Athletes in a One-Year Training Cycle.

Authors:  Ewa Anna Zarębska; Krzysztof Kusy; Ewa Maria Słomińska; Łukasz Kruszyna; Jacek Zieliński
Journal:  Metabolites       Date:  2019-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.